UNSPSC 51433505: Cryptenamine

This classification denotes an antihypertensive mixture of closely related hypotensive alkaloids from veratrum album. European Medicines Agency schedules Cryptenamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13498MIG.

UNSPSC 51433505 Cryptenamine is a Commodity code that covers pharmaceutical compounds used in emergency medical response. State and local governments procure medications under this code for fire rescue, emergency medical services, and hospital emergency departments. The Tampa Fire Rescue solicitation illustrates the scope: a sealed-bid procurement for advanced life support medications including epinephrine, labetalol, adenosine, and diltiazem used in acute cardiac and emergency interventions. Fire departments and emergency services are the primary end-users, though procurement may also flow through municipal purchasing departments, county health agencies, and special-purpose emergency services districts. Vendors must meet pharmaceutical-grade specifications, maintain expiration-date compliance (nine months or more from acceptance in the Tampa case), arrange for expired-material replacement, provide OSHA-compliant Safety Data Sheets, and deliver within tight timeframes (ten calendar days in Tampa's solicitation). Pricing is firm and includes shipping, freight on board, and applicable taxes.

The geographic profile remains limited to visible recent activity. The City of Tampa's Purchasing Department issued Bid No. 26P00188 as a sealed-bid IFB with response due April 8, 2026, for advanced life support medications valued at $40,000.00, with a one-year contract term and two optional renewal periods. The solicitation carries a Small Local Business Enterprise (SLBE) sheltered-market designation with a 5 percent bid discount (not to exceed $10,000) for SLBE participation. This single recent posting does not establish broader geographic concentration or repeat-buyer patterns under the code; additional recent solicitations would be needed to characterize the state and local market for cryptenamine compounds with confidence.